GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera AG (XTER:B8FK) » Definitions » Common Stock

Biofrontera AG (XTER:B8FK) Common Stock : €63.81 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Biofrontera AG Common Stock?

Biofrontera AG's quarterly common stock stayed the same from Jun. 2023 (€63.81 Mil) to Sep. 2023 (€63.81 Mil) and stayed the same from Sep. 2023 (€63.81 Mil) to Dec. 2023 (€63.81 Mil).

Biofrontera AG's annual common stock increased from Dec. 2021 (€56.72 Mil) to Dec. 2022 (€63.81 Mil) but then stayed the same from Dec. 2022 (€63.81 Mil) to Dec. 2023 (€63.81 Mil).


Biofrontera AG Common Stock Historical Data

The historical data trend for Biofrontera AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera AG Common Stock Chart

Biofrontera AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.85 47.75 56.72 63.81 63.81

Biofrontera AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.81 63.81 63.81 63.81 63.81

Biofrontera AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Biofrontera AG (XTER:B8FK) Business Description

Traded in Other Exchanges
Address
Hemmelrather Weg 201, Leverkusen, NW, DEU, 51377
Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.

Biofrontera AG (XTER:B8FK) Headlines

No Headlines